REQUEST A DEMO
Total
USD $0.00
Search more companies

Multiscan Pharma S.R.O. (Czech Republic)

Main Activities: Real Estate | Lessors of Other Real Estate Property
Secondary Activities: Offices of Physicians
Full name: Multiscan Pharma S.R.O. Profile Updated: October 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Multiscan Pharma S.R.O. is an enterprise in Czech Republic, with the main office in Prague. It operates in the Real Estate sector. It was first established on July 18, 2008. 25 - 49 (2024) employees currently work for Multiscan Pharma S.R.O.. In 2023, the company reported a net sales revenue increase of 7.59%. Its’ total assets recorded a growth of 4.93%. In 2023, Multiscan Pharma S.R.O.’s net profit margin decreased by 0.64%.

Headquarters
Okruhova 1135/44
Prague; The City of Prague; Postal Code: 15500

Contact Details: Purchase the Multiscan Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Multiscan Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Multiscan Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Multiscan Pharma S.R.O. report to view the information.
Incorporation Date:
July 18, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Multiscan Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
7.59%
Total operating revenue
7.71%
Operating profit (EBIT)
-22.9%
EBITDA
-16.8%
Net Profit (Loss) for the Period
-26.2%
Total assets
4.93%
Total equity
8.07%
Operating Profit Margin (ROS)
-0.7%
Net Profit Margin
-0.64%
Return on Equity (ROE)
-3.47%
Debt to Equity Ratio
0.55%
Quick Ratio
0.02%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?